NF-κB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression

Molecular and Cellular Biology

Volumn 22, Issue 15, 2002, Pages 5563-5574

  Nakamura, Yukio ^a   Grumont, Raelene J ^a   Gerondakis, Steve ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG; PROTEIN SUBUNIT;

ANIMAL CELL; ARTICLE; CARCINOGENICITY; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SYNCHRONIZATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; LYMPHOID CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TRANSGENE; ABELSON MURINE LEUKEMIA ONCOVIRUS; ANIMAL; B LYMPHOCYTE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CELL CYCLE G1 PHASE; DIMERIZATION; EXPERIMENTAL LEUKEMIA; GENETICS; LYMPHOID TISSUE; METABOLISM; MOUSE MUTANT; ONCOGENE; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; STEM CELL; SURVIVAL RATE; THYMOMA; VIROLOGY;

ABELSON MURINE LEUKEMIA VIRUS; ANIMALIA; MURINAE; MURINE LEUKEMIA VIRUS;

ABELSON MURINE LEUKEMIA VIRUS; ANIMALS; B-LYMPHOCYTES; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; DIMERIZATION; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ABL; LEUKEMIA, EXPERIMENTAL; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PROTEIN SUBUNITS; PROTO-ONCOGENE PROTEINS C-REL; STEM CELLS; SURVIVAL RATE; THYMOMA;

EID: 0035984145     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.15.5563-5574.2002     Document Type: Article

References (61)

1. Signaling by ABL oncogenes through cyclin D1
2. The NF-κB and IKB proteins: New discoveries and insights
3. Embryonic lethality and liver degeneration in mice lacking the relA component of NF-κB
4. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene
5. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl
6. 1
7. 1/S progression in fibroblasts
8. Jak-STAT signaling induced by the v-abl oncogene
9. Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation
10. NF-κB RelA deficient lymphocytes: Normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses
11. Transformation of bone marrow cells from Eμ-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus
12. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development
13. The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation
14. Genetic approaches in mice to understand Rel/NF-κB and IκB function: Transgenics and knockouts
15. Rel/NF-κB/IκB proteins and cancer
16. The Abelson murine leukemia virus oncogene
17. Multiple steps are required for the induction of tumors by Abelson murine leukemia virus
18. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression
19. The subunit composition of NF-κB complexes changes during B-cell development
20. B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) KBI transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells
21. -/- generates a nuclear isoform of the p50 precursor NF-κB1 that can function as a transactivator of NF-κB-regulated transcription
22. Rel/NF-κB transcription factors: Key mediators of B cell activation
23. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1
24. 1-to-S-phase transition
25. Site-directed mutagenesis by overlap extensions using the polymerase chain reaction
26. Failure of lymphopoiesis after adoptive transfer of NF-κB-deficient fetal liver cells
27. Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-κB-dependent pathway
28. The beginning of the end: IκB kinase (IKK) and NF-κB activation
29. The v-abl tyrosine kinase negatively regulates NF-κB/Rel factors and blocks κ gene transcription in pre-B lymphocytes
30. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity and interleukin-2 expression
31. Cell synchronization
32. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice
33. To cycle or not to cycle: A critical decision in cancer
34. Construction of a retro-virus packaging mutant and its use to produce helper-free defective retrovirus
35. Rel/NF-κβ and Iκβ proteins: An overview
36. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
37. CD40-mediated induction of p21 accumulation in resting and cycling B cells
38. Efficient selection for high-expression transfectants with a novel eukaryotic vector
39. 1 in mammalian fibroblasts
40. Arf induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation
41. Aberrant rel/nfkb genes and activity in human cancer
42. A requirement for NF-κB activation in Ber-Abl-mediated transformation
43. The viral and cellular forms of Abelson (abl) oncogene
44. Role of NF-κB in p53-mediated programmed cell death
45. Dominant negative MYC blocks transformation by ABL oncogene
46. Targeted disruption of the p50 subunit of NF-κB leads to muitifocal defects in immune responses
47. Structure, regulation and function of NF-κB
48. Genomic organization of the mouse cyclin DI gene (Cyl-1)
49. Identification of a novel bone marrow-derived B-cell progenitor population that coexpresses B220 and Thy-1 and is highly enriched for Abelson leukemia virus targets
50. p53 mediates apoptotic crisis in primary Abelson virus-transformed pre-B cells
51. Suppression of TNF-α-induced apoptosis by NF-κB
52. Autoimmunity as a consequence of retroviral mediated expression of c-FLIP in lymphocytes
53. Rel/NF-κB/IκB family: Intimate tales of association and dissociation
54. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
55. Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-Abl-transformed cells
56. Dependence of Dbl and Dbs transformation on MEK and NF-κB activation
57. IκB proteins: Structure, function and regulation
58. Progression of the transformed phenotype in clonal lines of Abelson virus-infected lymphocytes
59. Thyroid hormone regulates the mouse thyrotropin beta-subunit gene promoter in transfected primary thyrotropes
60. Induction of c-myc transcription by the v-Abl tyrosine kinase requires Ras, Raf1, and cyclin-dependent kinases
61. Signaling pathways activated by oncogenic forms of Abl tyrosine kinase